| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.32 | 0.2 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.29 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.28 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |